Innovation Pharmaceuticals Stock Market Value
| IPIX Stock | USD 0.0003 0.0001 25.00% |
| Symbol | Innovation |
Innovation Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Innovation Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Innovation Pharmaceuticals.
| 11/12/2024 |
| 12/12/2024 |
If you would invest 0.00 in Innovation Pharmaceuticals on November 12, 2024 and sell it all today you would earn a total of 0.00 from holding Innovation Pharmaceuticals or generate 0.0% return on investment in Innovation Pharmaceuticals over 30 days. Innovation Pharmaceuticals is related to or competes with Grey Cloak. Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat ... More
Innovation Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Innovation Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Innovation Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 53.43 | |||
| Information Ratio | 0.2522 | |||
| Maximum Drawdown | 286.67 | |||
| Value At Risk | (60.00) | |||
| Potential Upside | 100.0 |
Innovation Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innovation Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Innovation Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Innovation Pharmaceuticals historical prices to predict the future Innovation Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.1937 | |||
| Jensen Alpha | 13.92 | |||
| Total Risk Alpha | 5.3 | |||
| Sortino Ratio | 0.2613 | |||
| Treynor Ratio | 10.29 |
Innovation Pharmaceuticals Backtested Returns
Innovation Pharmaceuticals is out of control given 3 months investment horizon. Innovation Pharmaceuticals holds Efficiency (Sharpe) Ratio of 0.27, which attests that the entity had a 0.27% return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 14.75% are justified by taking the suggested risk. Use Innovation Pharmaceuticals Risk Adjusted Performance of 0.1937, market risk adjusted performance of 10.3, and Downside Deviation of 53.43 to evaluate company specific risk that cannot be diversified away. Innovation Pharmaceuticals holds a performance score of 21 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 1.37, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Innovation Pharmaceuticals will likely underperform. Use Innovation Pharmaceuticals maximum drawdown, as well as the relationship between the skewness and price action indicator , to analyze future returns on Innovation Pharmaceuticals.
Auto-correlation | 0.56 |
Modest predictability
Innovation Pharmaceuticals has modest predictability. Overlapping area represents the amount of predictability between Innovation Pharmaceuticals time series from 12th of November 2024 to 27th of November 2024 and 27th of November 2024 to 12th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Innovation Pharmaceuticals price movement. The serial correlation of 0.56 indicates that roughly 56.0% of current Innovation Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.56 | |
| Spearman Rank Test | 0.78 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Innovation Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Innovation Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Innovation Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Innovation Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Innovation Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Innovation Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Innovation Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Innovation Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Innovation Pharmaceuticals pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Innovation Pharmaceuticals Lagged Returns
When evaluating Innovation Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Innovation Pharmaceuticals pink sheet have on its future price. Innovation Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Innovation Pharmaceuticals autocorrelation shows the relationship between Innovation Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Innovation Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Innovation Pink Sheet Analysis
When running Innovation Pharmaceuticals' price analysis, check to measure Innovation Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation Pharmaceuticals is operating at the current time. Most of Innovation Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Innovation Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation Pharmaceuticals' price. Additionally, you may evaluate how the addition of Innovation Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.